
Conference Coverage
about 5 hours ago
Cemiplimab Response Tied to Longer Quality-of-Life Benefit in aNSCLCLatest Content

Cemiplimab Response Tied to Longer Quality-of-Life Benefit in aNSCLC

Acne Treatment Adherence Ranges From 6% to 84% in Real-World Studies

Value-Based Pilot for Medicaid Members With Substance Use Disorder

Preventing High-Cost Failure: A Value-Based Approach to Reducing Diabetic Limb Loss in US Managed Care

FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor

Shorts










Center on Health Equity & Access
All News

Pooled real-world data show an 88% response rate with brexu-cel in relapsed mantle cell lymphoma (MCL), but cost and QOL data are scarce.

Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.

This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.

During OncoVenture, Careology leaders described how their platform supports patients receiving CAR T-cell therapy at home in Ohio, extends Mayo Clinic’s reach in rural Florida, and powers payer care navigation.

John Elliott, of Reimagine Care, outlined a model that pairs AI-supported triage with oncology-trained nurses, and the CEO of a large Texas practice described how the partnership has grown to include patients receiving CAR T-cell therapy.

Anemia and iron deficiency are linked to higher odds of acute heart failure during pregnancy and after childbirth, according to a study.

This commentary highlights limitations of traditional access metrics and proposes incorporating eConsults to better capture specialty capacity, workload, and performance in modern health care delivery.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Among 821,327 outpatients, cystatin C–based eGFR at least 30% below creatinine-based eGFR was linked to higher death and heart failure rates.

Faculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the gap.



























